Impact of Tracheal Cuff Shape on Microaspiration in Intensive Care Units

NCT ID: NCT01948635

Last Updated: 2025-12-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

326 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-04-30

Study Completion Date

2015-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators hypothesized that PVC tapered-cuff tracheal tubes would reduce microaspiration of gastric content as determined by pepsin level in tracheal aspirate.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Microaspiration is the main route for entry of contaminated secretions into the lower respiratory tract of intubated critically ill patients. Tracheobronchial colonization might progress to ventilator-associated pneumonia (VAP) when the quantity and virulence of bacteria are high and when local and general host defenses are weak.

Recent in vitro and animal studies suggest that tapered-cuff tracheal tubes could be associated with reduced microaspiration of contaminated secretions and might be helpful in preventing VAP.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Illness Mechanical Ventilation Complication Ventilator Associated Pneumonia

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

tracheal cuff shape microaspiration pepsin ventilator-associated pneumonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

tapered PVC-cuffed tracheal tubes

Patients in this arm will be intubated with tapered PVC-tracheal tubes

Group Type EXPERIMENTAL

tapered PVC-cuffed tracheal tubes

Intervention Type DEVICE

Patients will be intubated with tapered-shape tracheal tubes

Standard PVC-cuffed tracheal tube

Patients in this arm will be intubated with standard (barrel-shape cuffed) PVC tracheal tubes

Group Type ACTIVE_COMPARATOR

Standard PVC-cuffed tracheal tube

Intervention Type DEVICE

Patients will be intubated with standard PVC cuffed tracheal tubes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

tapered PVC-cuffed tracheal tubes

Patients will be intubated with tapered-shape tracheal tubes

Intervention Type DEVICE

Standard PVC-cuffed tracheal tube

Patients will be intubated with standard PVC cuffed tracheal tubes

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age \> or = 18 years
* tracheal intubation
* predictable duration of mechanical ventilation \> 48h
* enteral nutrition

Exclusion Criteria

* pregnant women
* refuse to participate to the study
* no informed consent
* contre indication for semirecumbent position
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Lille

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Saad Nseir, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

CHRU de Lille

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

ICU, Salengro Hospital, University Hospital of Lille

Lille, Nord, France

Site Status

centre Hospitalier

Boulogne-sur-Mer, , France

Site Status

Centre Hospitalier

Dunkirk, , France

Site Status

Centre Hospitalier

Lens, , France

Site Status

Centre Hospitalier St Philibert

Lomme, , France

Site Status

Centre hospitalier

Roubaix, , France

Site Status

Centre Hospitalier Universitaire

Rouen, , France

Site Status

Centre Hospitalie

Tourcoing, , France

Site Status

Centre Hospitalier

Valenciennes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Jaillette E, Brunin G, Girault C, Zerimech F, Chiche A, Broucqsault-Dedrie C, Fayolle C, Minacori F, Alves I, Barrailler S, Robriquet L, Tamion F, Delaporte E, Thellier D, Delcourte C, Duhamel A, Nseir S. Impact of tracheal cuff shape on microaspiration of gastric contents in intubated critically ill patients: study protocol for a randomized controlled trial. Trials. 2015 Sep 25;16:429. doi: 10.1186/s13063-015-0955-z.

Reference Type BACKGROUND
PMID: 26407612 (View on PubMed)

Jaillette E, Girault C, Brunin G, Zerimech F, Behal H, Chiche A, Broucqsault-Dedrie C, Fayolle C, Minacori F, Alves I, Barrailler S, Labreuche J, Robriquet L, Tamion F, Delaporte E, Thellier D, Delcourte C, Duhamel A, Nseir S; BestCuff Study Group and the BoReal Network. Impact of tapered-cuff tracheal tube on microaspiration of gastric contents in intubated critically ill patients: a multicenter cluster-randomized cross-over controlled trial. Intensive Care Med. 2017 Nov;43(11):1562-1571. doi: 10.1007/s00134-017-4736-x. Epub 2017 Mar 16.

Reference Type RESULT
PMID: 28303301 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2012_45

Identifier Type: -

Identifier Source: org_study_id

2013 A00534 41

Identifier Type: OTHER

Identifier Source: secondary_id

PHRCI_2012

Identifier Type: OTHER

Identifier Source: secondary_id